Theme and variations on kinetics of GPCR activation/deactivation

References

• Jacoby E, Bouhelal R, Gerspacher M, Seuwen K. The 7 TM G-protein-coupled receptor target family. ChemMedChem 2006, 1, 761–782.
   PubMed Web of Science ®Google Scholar
• Pierce KL, Premont RT, Lefkowitz RJ. Seven-transmembrane receptors. Nat Rev Mol Cell Biol 2002, 3, 639–650.
   PubMed Web of Science ®Google Scholar
• Kristiansen K. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol Ther 2004, 103, 21–80.
   PubMed Web of Science ®Google Scholar
• Rasmussen SG, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, Edwards PC, Burghammer M, Ratnala VR, Sanishvili R, Fischetti RF, Schertler GF, Weis WI, Kobilka BK. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 2007, 450, 383–387.
   PubMed Web of Science ®Google Scholar
• Rosenbaum DM, Rasmussen SG, Kobilka BK. The structure and function of G-protein-coupled receptors. Nature 2009, 459, 356–363.
   PubMed Web of Science ®Google Scholar
• Bourne HR, Sanders DA, McCormick F. The GTPase superfamily: conserved structure and molecular mechanism. Nature 1991, 349, 117–127.
   PubMed Web of Science ®Google Scholar
• Linderman JJ. Modeling of G-protein-coupled receptor signaling pathways. J Biol Chem 2009, 284, 5427–5431.
   PubMed Web of Science ®Google Scholar
• Kaziro Y, Itoh H, Kozasa T, Nakafuku M, Satoh T. Structure and function of signal-transducing GTP-binding proteins. Annu Rev Biochem 1991, 60, 349–400.
   PubMedGoogle Scholar
• Selinger Z. Discovery of G protein signaling. Annu Rev Biochem 2008, 77, 1–13.
   Google Scholar
• Lambert NA. Uncoupling diffusion and binding in FRAP experiments. Nat Methods 2009, 6, 183; author reply 183–183; author reply 184.
   Google Scholar
• Janetopoulos C, Jin T, Devreotes P. Receptor-mediated activation of heterotrimeric G-proteins in living cells. Science 2001, 291, 2408–2411.
   PubMed Web of Science ®Google Scholar
• Bünemann M, Frank M, Lohse MJ. Gi protein activation in intact cells involves subunit rearrangement rather than dissociation. Proc Natl Acad Sci USA 2003, 100, 16077–16082.
   PubMed Web of Science ®Google Scholar
• Galés C, Van Durm JJ, Schaak S, Pontier S, Percherancier Y, Audet M, Paris H, Bouvier M. Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes. Nat Struct Mol Biol 2006, 13, 778–786.
   PubMed Web of Science ®Google Scholar
• Yi TM, Kitano H, Simon MI. A quantitative characterization of the yeast heterotrimeric G protein cycle. Proc Natl Acad Sci USA 2003, 100, 10764–10769.
   PubMed Web of Science ®Google Scholar
• Wettschureck N, Offermanns S. Mammalian G proteins and their cell type specific functions. Physiol Rev 2005, 85, 1159–1204.
   PubMed Web of Science ®Google Scholar
• Smrcka AV. G protein betagamma subunits: central mediators of G protein-coupled receptor signaling. Cell Mol Life Sci 2008, 65, 2191–2214.
   PubMed Web of Science ®Google Scholar
• Dupré DJ, Robitaille M, Rebois RV, Hébert TE. The role of Gbetagamma subunits in the organization, assembly, and function of GPCR signaling complexes. Annu Rev Pharmacol Toxicol 2009, 49, 31–56.
   PubMed Web of Science ®Google Scholar
• Lamb TD. Gain and kinetics of activation in the G-protein cascade of phototransduction. Proc Natl Acad Sci USA 1996, 93, 566–570.
   PubMedGoogle Scholar
• Pugh EN Jr, Lamb TD. Amplification and kinetics of the activation steps in phototransduction. Biochim Biophys Acta 1993, 1141, 111–149.
   Google Scholar
• Vilardaga JP, Bünemann M, Feinstein TN, Lambert N, Nikolaev VO, Engelhardt S, Lohse MJ, Hoffmann C. GPCR and G proteins: drug efficacy and activation in live cells. Mol Endocrinol 2009, 23, 590–599.
   Google Scholar
• Ross EM. Coordinating speed and amplitude in G-protein signaling. Curr Biol 2008, 18, R777–R783.
   PubMed Web of Science ®Google Scholar
• Turcotte M, Tang W, Ross EM. Coordinate regulation of G protein signaling via dynamic interactions of receptor and GAP. PLoS Comput Biol 2008, 4, e1000148.
   Google Scholar
• Farrens DL, Altenbach C, Yang K, Hubbell WL, Khorana HG. Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science 1996, 274, 768–770.
   PubMed Web of Science ®Google Scholar
• Altenbach C, Yang K, Farrens DL, Farahbakhsh ZT, Khorana HG, Hubbell WL. Structural features and light-dependent changes in the cytoplasmic interhelical E-F loop region of rhodopsin: a site-directed spin-labeling study. Biochemistry 1996, 35, 12470–12478.
   PubMed Web of Science ®Google Scholar
• Farahbakhsh ZT, Hideg K, Hubbell WL. Photoactivated conformational changes in rhodopsin: a time-resolved spin label study. Science 1993, 262, 1416–1419.
   Google Scholar
• Yao X, Parnot C, Deupi X, Ratnala VR, Swaminath G, Farrens D, Kobilka B. Coupling ligand structure to specific conformational switches in the beta2-adrenoceptor. Nat Chem Biol 2006, 2, 417–422.
   PubMed Web of Science ®Google Scholar
• Jensen AD, Guarnieri F, Rasmussen SG, Asmar F, Ballesteros JA, Gether U. Agonist-induced conformational changes at the cytoplasmic side of transmembrane segment 6 in the beta 2 adrenergic receptor mapped by site-selective fluorescent labeling. J Biol Chem 2001, 276, 9279–9290.
   PubMed Web of Science ®Google Scholar
• Gether U, Lin S, Kobilka BK. Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes. J Biol Chem 1995, 270, 28268–28275.
   PubMed Web of Science ®Google Scholar
• Castro M, Nikolaev VO, Palm D, Lohse MJ, Vilardaga JP. Turn-on switch in parathyroid hormone receptor by a two-step parathyroid hormone binding mechanism. Proc Natl Acad Sci USA 2005, 102, 16084–16089.
   PubMed Web of Science ®Google Scholar
• Ferrandon S, Feinstein TN, Castro M, Wang B, Bouley R, Potts JT, Gardella TJ, Vilardaga JP. Sustained cyclic AMP production by parathyroid hormone receptor endocytosis. Nat Chem Biol 2009, 5, 734–742.
   PubMed Web of Science ®Google Scholar
• Palanche T, Ilien B, Zoffmann S, Reck MP, Bucher B, Edelstein SJ, Galzi JL. The neurokinin A receptor activates calcium and cAMP responses through distinct conformational states. J Biol Chem 2001, 276, 34853–34861.
   Web of Science ®Google Scholar
• Lecat S, Bucher B, Mely Y, Galzi JL. Mutations in the extracellular amino-terminal domain of the NK2 neurokinin receptor abolish cAMP signaling but preserve intracellular calcium responses. J Biol Chem 2002, 277, 42034–42048.
   Google Scholar
• Vilardaga JP, Bünemann M, Krasel C, Castro M, Lohse MJ. Measurement of the millisecond activation switch of G protein-coupled receptors in living cells. Nat Biotechnol 2003, 21, 807–812.
   PubMed Web of Science ®Google Scholar
• Dean T, Vilardaga JP, Potts JT Jr, Gardella TJ. Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH/PTHrP receptor. Mol Endocrinol 2008, 22, 156–166.
   PubMed Web of Science ®Google Scholar
• Dean T, Linglart A, Mahon MJ, Bastepe M, Jüppner H, Potts JT Jr, Gardella TJ. Mechanisms of ligand binding to the parathyroid hormone (PTH)/PTH-related protein receptor: selectivity of a modified PTH(1-15) radioligand for GalphaS-coupled receptor conformations. Mol Endocrinol 2006, 20, 931–943.
   Google Scholar
• Lohse MJ, Bünemann M, Hoffmann C, Vilardaga JP, Nikolaev VO. Monitoring receptor signaling by intramolecular FRET. Curr Opin Pharmacol 2007, 7, 547–553.
   Google Scholar
• Lohse MJ, Hoffmann C, Nikolaev VO, Vilardaga JP, Bünemann M. Kinetic analysis of G protein-coupled receptor signaling using fluorescence resonance energy transfer in living cells. Adv Protein Chem 2007, 74, 167–188.
   PubMedGoogle Scholar
• Lohse MJ, Nikolaev VO, Hein P, Hoffmann C, Vilardaga JP, Bünemann M. Optical techniques to analyze real-time activation and signaling of G-protein-coupled receptors. Trends Pharmacol Sci 2008, 29, 159–165.
   PubMed Web of Science ®Google Scholar
• Lohse MJ, Vilardaga JP, Bünemann M. Molecular mechanisms of receptor activation: real-time analysis by fluorescence resonance energy transfer. Auton Autacoid Pharmacol 2003, 23, 231–233.
   Google Scholar
• Hoffmann C, Gaietta G, Bünemann M, Adams SR, Oberdorff-Maass S, Behr B, Vilardaga JP, Tsien RY, Ellisman MH, Lohse MJ. A FlAsH-based FRET approach to determine G protein-coupled receptor activation in living cells. Nat Methods 2005, 2, 171–176.
   PubMed Web of Science ®Google Scholar
• Vilardaga JP, Steinmeyer R, Harms GS, Lohse MJ. Molecular basis of inverse agonism in a G protein-coupled receptor. Nat Chem Biol 2005, 1, 25–28.
   PubMed Web of Science ®Google Scholar
• Vilardaga JP, Nikolaev VO, Lorenz K, Ferrandon S, Zhuang Z, Lohse MJ. Conformational cross-talk between alpha2A-adrenergic and mu-opioid receptors controls cell signaling. Nat Chem Biol 2008, 4, 126–131.
   PubMed Web of Science ®Google Scholar
• Maier-Peuschel M, Frölich N, Dees C, Hommers LG, Hoffmann C, Nikolaev VO, Lohse MJ. A fluorescence resonance energy transfer-based M2 muscarinic receptor sensor reveals rapid kinetics of allosteric modulation. J Biol Chem 2010, 285, 8793–8800.
   PubMed Web of Science ®Google Scholar
• Rochais F, Vilardaga JP, Nikolaev VO, Bünemann M, Lohse MJ, Engelhardt S. Real-time optical recording of beta1-adrenergic receptor activation reveals supersensitivity of the Arg389 variant to carvedilol. J Clin Invest 2007, 117, 229–235.
   PubMed Web of Science ®Google Scholar
• Nakanishi J, Takarada T, Yunoki S, Kikuchi Y, Maeda M. FRET-based monitoring of conformational change of the beta2 adrenergic receptor in living cells. Biochem Biophys Res Commun 2006, 343, 1191–1196.
   Google Scholar
• Jensen JB, Lyssand JS, Hague C, Hille B. Fluorescence changes reveal kinetic steps of muscarinic receptor-mediated modulation of phosphoinositides and Kv7.2/7.3 K+ channels. J Gen Physiol 2009, 133, 347–359.
   Google Scholar
• Falkenburger BH, Jensen JB, Hille B. Kinetics of M1 muscarinic receptor and G protein signaling to phospholipase C in living cells. J Gen Physiol 2010, 135, 81–97.
   Google Scholar
• Hein P, Rochais F, Hoffmann C, Dorsch S, Nikolaev VO, Engelhardt S, Berlot CH, Lohse MJ, Bünemann M. Gs activation is time-limiting in initiating receptor-mediated signaling. J Biol Chem 2006, 281, 33345–33351.
   PubMed Web of Science ®Google Scholar
• Kenakin T. Drug efficacy at G protein-coupled receptors. Annu Rev Pharmacol Toxicol 2002, 42, 349–379.
   PubMedGoogle Scholar
• Kenakin T. Efficacy at G-protein-coupled receptors. Nat Rev Drug Discov 2002, 1, 103–110.
   PubMed Web of Science ®Google Scholar
• Nikolaev VO, Hoffmann C, Bünemann M, Lohse MJ, Vilardaga JP. Molecular basis of partial agonism at the neurotransmitter alpha2A-adrenergic receptor and Gi-protein heterotrimer. J Biol Chem 2006, 281, 24506–24511.
   PubMed Web of Science ®Google Scholar
• Swaminath G, Xiang Y, Lee TW, Steenhuis J, Parnot C, Kobilka BK. Sequential binding of agonists to the beta2 adrenoceptor. Kinetic evidence for intermediate conformational states. J Biol Chem 2004, 279, 686–691.
   PubMed Web of Science ®Google Scholar
• Swaminath G, Deupi X, Lee TW, Zhu W, Thian FS, Kobilka TS, Kobilka B. Probing the beta2 adrenoceptor binding site with catechol reveals differences in binding and activation by agonists and partial agonists. J Biol Chem 2005, 280, 22165–22171.
   PubMed Web of Science ®Google Scholar
• Seifert R, Gether U, Wenzel-Seifert K, Kobilka BK. Effects of guanine, inosine, and xanthine nucleotides on beta(2)-adrenergic receptor/G(s) interactions: evidence for multiple receptor conformations. Mol Pharmacol 1999, 56, 348–358.
   PubMed Web of Science ®Google Scholar
• Seifert R, Wenzel-Seifert K, Gether U, Kobilka BK. Functional differences between full and partial agonists: evidence for ligand-specific receptor conformations. J Pharmacol Exp Ther 2001, 297, 1218–1226.
   PubMed Web of Science ®Google Scholar
• Ghanouni P, Gryczynski Z, Steenhuis JJ, Lee TW, Farrens DL, Lakowicz JR, Kobilka BK. Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta 2 adrenergic receptor. J Biol Chem 2001, 276, 24433–24436.
   PubMed Web of Science ®Google Scholar
• May LT, Leach K, Sexton PM, Christopoulos A. Allosteric modulation of G protein-coupled receptors. Annu Rev Pharmacol Toxicol 2007, 47, 1–51.
   PubMedGoogle Scholar
• Christopoulos A, Kenakin T. G protein-coupled receptor allosterism and complexing. Pharmacol Rev 2002, 54, 323–374.
   PubMed Web of Science ®Google Scholar
• Kenakin T, Miller LJ. Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacol Rev 2010, 62, 265–304.
   PubMed Web of Science ®Google Scholar
• Fuxe K, Marcellino D, Rivera A, Diaz-Cabiale Z, Filip M, Gago B, Roberts DC, Langel U, Genedani S, Ferraro L, de la Calle A, Narvaez J, Tanganelli S, Woods A, Agnati LF. Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology. Brain Res Rev 2008, 58, 415–452.
   PubMedGoogle Scholar
• Fuxe K, Marcellino D, Guidolin D, Woods AS, Agnati LF. Heterodimers and receptor mosaics of different types of G-protein-coupled receptors. Physiology (Bethesda) 2008, 23, 322–332.
   PubMed Web of Science ®Google Scholar
• Fuxe K, Canals M, Torvinen M, Marcellino D, Terasmaa A, Genedani S, Leo G, Guidolin D, Diaz-Cabiale Z, Rivera A, Lundstrom L, Langel U, Narvaez J, Tanganelli S, Lluis C, Ferré S, Woods A, Franco R, Agnati LF. Intramembrane receptor-receptor interactions: a novel principle in molecular medicine. J Neural Transm 2007, 114, 49–75.
   PubMed Web of Science ®Google Scholar
• Jordan BA, Gomes I, Rios C, Filipovska J, Devi LA. Functional interactions between mu opioid and alpha 2A-adrenergic receptors. Mol Pharmacol 2003, 64, 1317–1324.
   PubMed Web of Science ®Google Scholar
• Hein P, Frank M, Hoffmann C, Lohse MJ, Bünemann M. Dynamics of receptor/G protein coupling in living cells. EMBO J 2005, 24, 4106–4114.
   PubMed Web of Science ®Google Scholar
• Azpiazu I, Gautam N. A fluorescence resonance energy transfer-based sensor indicates that receptor access to a G protein is unrestricted in a living mammalian cell. J Biol Chem 2004, 279, 27709–27718.
   Google Scholar
• Frank M, Thümer L, Lohse MJ, Bünemann M. G Protein activation without subunit dissociation depends on a G{alpha}(i)-specific region. J Biol Chem 2005, 280, 24584–24590.
   PubMed Web of Science ®Google Scholar
• Lambert NA. Dissociation of heterotrimeric g proteins in cells. Sci Signal 2008, 1, re5.
   Google Scholar
• Saini DK, Karunarathne WK, Angaswamy N, Saini D, Cho JH, Kalyanaraman V, Gautam N. Regulation of Golgi structure and secretion by receptor-induced G protein {beta}{gamma} complex translocation. Proc Natl Acad Sci USA 2010, 107, 11417–11422.
   Google Scholar
• Saini DK, Chisari M, Gautam N. Shuttling and translocation of heterotrimeric G proteins and Ras. Trends Pharmacol Sci 2009, 30, 278–286.
   Google Scholar
• Chisari M, Saini DK, Kalyanaraman V, Gautam N. Shuttling of G protein subunits between the plasma membrane and intracellular membranes. J Biol Chem 2007, 282, 24092–24098.
   PubMedGoogle Scholar
• Akgoz M, Kalyanaraman V, Gautam N. G protein betagamma complex translocation from plasma membrane to Golgi complex is influenced by receptor gamma subunit interaction. Cell Signal 2006, 18, 1758–1768.
   PubMedGoogle Scholar
• Xie GX, Palmer PP. How regulators of G protein signaling achieve selective regulation. J Mol Biol 2007, 366, 349–365.
   PubMed Web of Science ®Google Scholar